Atai Life Sciences Shares Outstanding 2020-2024 | ATAI
Atai Life Sciences shares outstanding from 2020 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Atai Life Sciences Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 159 |
| 2022 | 156 |
| 2021 | 138 |
| 2020 | 93 |
| 2019 | 87 |
| Atai Life Sciences Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-09-30 | 161 |
| 2024-06-30 | 160 |
| 2024-03-31 | 159 |
| 2023-12-31 | 159 |
| 2023-09-30 | 178 |
| 2023-06-30 | 156 |
| 2023-03-31 | 156 |
| 2022-12-31 | 156 |
| 2022-09-30 | 157 |
| 2022-06-30 | 154 |
| 2022-03-31 | 154 |
| 2021-12-31 | 138 |
| 2021-09-30 | 151 |
| 2021-06-30 | 132 |
| 2021-03-31 | 121 |
| 2020-12-31 | 93 |
| 2020-09-30 | 91 |
| 2020-06-30 | 91 |
| 2020-03-31 | 94 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.245B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $20.877B | 0.00 |
| Quest Diagnostics (DGX) | United States | $16.876B | 17.10 |
| DaVita (DVA) | United States | $13.632B | 17.63 |
| Encompass Health (EHC) | United States | $9.545B | 22.50 |
| Chemed (CHE) | United States | $8.349B | 25.66 |
| Elanco Animal Health (ELAN) | United States | $5.942B | 14.14 |
| Option Care Health (OPCH) | United States | $4.962B | 23.52 |
| RadNet (RDNT) | United States | $4.431B | 98.13 |
| LifeStance Health (LFST) | United States | $3.057B | 0.00 |
| Amedisys (AMED) | United States | $3.010B | 21.42 |
| Addus HomeCare (ADUS) | United States | $2.427B | 28.48 |
| Astrana Health (ASTH) | United States | $1.978B | 27.05 |
| U.S Physical Therapy (USPH) | United States | $1.337B | 35.14 |
| Pennant (PNTG) | United States | $0.943B | 38.14 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.899B | 0.00 |
| Bioqual (BIOQ) | United States | $0.058B | 0.00 |
| Daxor (DXR) | United States | $0.041B | 0.00 |
| Ontrak (OTRK) | United States | $0.007B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.005B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.003B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |